Improve Medical Instruments Co Ltd
SZSE:300030
Intrinsic Value
Improve Medical Instruments Co., Ltd. engages in the provision of clinical care and testing laboratory. [ Read More ]
The intrinsic value of one Improve Medical Instruments Co Ltd stock under the Base Case scenario is 4.1 CNY. Compared to the current market price of 4.76 CNY, Improve Medical Instruments Co Ltd is Overvalued by 14%.
Valuation Backtest
Improve Medical Instruments Co Ltd
Run backtest to discover the historical profit from buying and selling Improve Medical Instruments Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Improve Medical Instruments Co Ltd
| Current Assets | 716.5m |
| Cash & Short-Term Investments | 236.9m |
| Receivables | 239.8m |
| Other Current Assets | 239.8m |
| Non-Current Assets | 756.3m |
| Long-Term Investments | 252.3m |
| PP&E | 370.1m |
| Intangibles | 69.1m |
| Other Non-Current Assets | 64.8m |
| Current Liabilities | 572.8m |
| Accounts Payable | 80.5m |
| Accrued Liabilities | 19.9m |
| Short-Term Debt | 375.9m |
| Other Current Liabilities | 96.5m |
| Non-Current Liabilities | 112.5m |
| Long-Term Debt | 28.3m |
| Other Non-Current Liabilities | 84.2m |
Earnings Waterfall
Improve Medical Instruments Co Ltd
|
Revenue
|
653.6m
CNY
|
|
Cost of Revenue
|
-415.5m
CNY
|
|
Gross Profit
|
238.1m
CNY
|
|
Operating Expenses
|
-387.3m
CNY
|
|
Operating Income
|
-149.2m
CNY
|
|
Other Expenses
|
11.9m
CNY
|
|
Net Income
|
-137.3m
CNY
|
Free Cash Flow Analysis
Improve Medical Instruments Co Ltd
Profitability Score
Profitability Due Diligence
Improve Medical Instruments Co Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Score
Improve Medical Instruments Co Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Improve Medical Instruments Co Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
Improve Medical Instruments Co Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Improve Medical Instruments Co Ltd
According to Wall Street analysts, the average 1-year price target for Improve Medical Instruments Co Ltd is 13.44 CNY .
Shareholder Return
Price
Improve Medical Instruments Co Ltd
| Average Annual Return | 13.09% |
| Standard Deviation of Annual Returns | 45.32% |
| Max Drawdown | -77% |
| Market Capitalization | 1.5B CNY |
| Shares Outstanding | 309 187 315 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Improve Medical Instruments Co., Ltd. engages in the provision of clinical care and testing laboratory. The company is headquartered in Guangzhou, Guangdong and currently employs 1,017 full-time employees. The company went IPO on 2009-12-25. The firm is also engaged in the financial leasing business of medical equipment. The firm's products include vacuum blood collection systems, liquid biopsy tubes, automatic blood collection tube detachers, thromboelastometers and reagents, hospital intelligent blood collection management systems, sub-medical record systems (EMR) and others. The firm's products also include masks, instruments, reagents and others. The firm's products are exported to Russia, Saudi Arabia, Brazil, South Korea and other countries and regions.
Contact
IPO
Employees
Officers
The intrinsic value of one Improve Medical Instruments Co Ltd stock under the Base Case scenario is 4.1 CNY.
Compared to the current market price of 4.76 CNY, Improve Medical Instruments Co Ltd is Overvalued by 14%.
You don't have any saved screeners yet
